Frontlight ResearchEarly access
Trial site
Gabinet Okulistyczny Prof Edward Wylegala
- 6running trials
- 5closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Macular degeneration6 trials
- Diabetic eye disease3 trials
- Phase
- Phase 36 trials
- Phase 2/33 trials
- Phase 22 trials
- Status
- Completed5 trials
- Active, not recruiting2 trials
- Not yet recruiting2 trials
- Recruiting2 trials
- Lead sponsor
- Hoffmann-La Roche4 trials
- Eyebiotech Limited2 trials
- EyeBiotech Ltd.1 trial
- Lupin Ltd.1 trial
- Merck Sharp & Dohme LLC1 trial
- and 2 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Macular degeneration3 recruiting
- Diabetic eye disease1 recruiting
Closed trials
Completed
Completed
Completed
A Study to Investigate Vamikibart in Participants With Uveitic Macular Edema
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026